How Neurovalens moved to remote clinical trials during Covid-19

August 5, 2020

With signs of a second wave of Covid-19 hitting Europe, there is a need for digital tech company founders to remain resilient. Amid the doom and gloom there is reason to be positive, with recent figures demonstrating that investors are continuing to back promising UK tech teams despite the challenges posed by the pandemic.

Belfast and San Diego-based Neurovalens, a Tech Nation Upscale 5.0 cohort member and Angel CoFund portfolio company, is a case in point. Made in Northern Ireland, the company’s non-invasive neurostimulation devices – which resemble wearable headbands – solve global problems such as obesity; diabetes; anxiety and insomnia without the need for implanted electrodes.

You can read the full article on Tech Nation website here.